Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
BMC Health Serv Res ; 23(1): 7, 2023 Jan 04.
Article in English | MEDLINE | ID: covidwho-2196262

ABSTRACT

BACKGROUND: India, the seventh-largest country in the world and the second-most populated faces enormous challenges when it comes to healthcare. The country's healthcare system was close to collapse due to the detrimental effects of the COVID-19 pandemic. Telehealth, which enables treating patients remotely, played a critical role during these challenging times. This systematic review investigates in detail the role of telehealth during COVID-19 and its application beyond the pandemic. METHODS: Database searches on PubMed, Scopus, Science Direct and Web of Science were carried out for studies published on telehealth, and articles were included if they focused on any audio or video telehealth consultation during the pandemic in India. Findings were synthesised into three main themes: applications, benefits and challenges of telehealth services. Methodological quality was assessed using JBI critical appraisal tools. RESULTS: The initial search on databases yielded 1143 articles. Of those, 19 met the eligibility criteria. Findings highlight the effective utilisation of telehealth across multiple medical specialities. Although insufficient technological infrastructure and other barriers due to the virtual consultation challenge the successful implementation of telehealth in India, it has the potential to bridge the rural-urban healthcare divide with cost-effective and easily accessible services. CONCLUSION: High patient/provider satisfaction underscores the need to integrate telehealth into routine healthcare practices in the country. However, the review urges the government and healthcare practitioners to address the telehealth challenges with prime importance to ensure quality healthcare throughout the nation even after the pandemic.


Subject(s)
COVID-19 , Telemedicine , Humans , COVID-19/epidemiology , Pandemics , Quality of Health Care , Health Facilities
2.
McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Dara Reddy, Varaprasad Babu, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, Dsouza, Hyjel, Dummer, Jack, Dutta, Sourabh, Foo, Hong, Gilbey, Timothy, Giles, Michelle, Goli, Kasiram, Gordon, Adrienne, Gyanwali, Pradip, Hudson, Bernard, Jani, Manoj, Jevaji, Purnima, Jhawar, Sachin, Jindal, Aikaj, John, M. Joseph, John, Mary, John, Flavita, John, Oommen, Jones, Mark, Joshi, Rajesh, Kamath, Prashanthi, Kang, Gagandeep, Karki, Achyut, Karmalkar, Abhishek, Kaur, Baldeep, Koganti, Kalyan Chakravarthy, Koshy, Jency, Mathew, S. K.; Lau, Jilllian, Lewin, Sharon, Lim, Lyn-li, Marschner, Ian, Marsh, Julie, Maze, Michael, McGree, James, McMahon, James, Medcalf, Robert, Merriman, Eileen, Misal, Amol, Mora, Jocelyn, Mudaliar, Vijaybabu, Nguyen, Vi, O'Sullivan, Matthew, Pant, Suman, Pant, Pankaj, Paterson, David, Price, David, Rees, Megan, Robinson, James Owen, Rogers, Benjamin, Samuel, Sandhya, Sasadeusz, Joe, Sharma, Deepak, Sharma, Prabhat, Shrestha, Roshan, Shrestha, Sailesh, Shrestha, Prajowl, Shukla, Urvi, Shum, Omar, Sommerville, Christine, Spelman, Tim, Sullivan, Richard, Thatavarthi, Umashankar, Tran, Huyen, Trask, Nanette, Whitehead, Claire, Mahar, Robert, Hammond, Naomi, McFadyen, James David, Snelling, Thomas, Davis, Joshua, Denholm, Justin, Tong, Steven Y. C..
Blood ; 140:326-328, 2022.
Article in English | ScienceDirect | ID: covidwho-2120231
3.
Vaccines (Basel) ; 10(11)2022 Oct 22.
Article in English | MEDLINE | ID: covidwho-2082213

ABSTRACT

Vaccine hesitancy plays a crucial role in worldwide pandemic-control efforts. The multifaceted nature of vaccine hesitancy entails many psychological factors that are widely discussed in the literature, although few studies specifically compile these factors. Thus, this systematic review aims to synthesize the psychological factors contributing to vaccine hesitancy. As per the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines, a systematic search was conducted on electronic databases PubMed, Scopus, Science Direct, PsycNET, and Web of Science, and a manual search was conducted on Google Scholar. Out of the 2289 articles obtained, 79 studies that met the inclusion criteria were deemed eligible for the review. The findings highlight appraisals of the COVID-19 pandemic, vaccine safety and side effects, vaccine confidence/trust, trust in government and healthcare professionals, scepticism around vaccine production, conspiracy beliefs, emotions, and information and knowledge about the vaccine as the major psychological factors contributing to vaccine hesitancy. Concerningly, misinformation on COVID-19 vaccination spread through social media platforms, increasing vaccine hesitancy. Recommendations for government authorities, healthcare professionals, and implications for future research are also outlined.

4.
Heliyon ; 8(6): e09765, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1991053

ABSTRACT

Background: Though quarantine is a pertinent control measure for the spread of COVID-19, it is equally important to consider its negative impacts, as it causes severe psychological, emotional, and financial problems not only for those who are quarantined but also for many others who are directly or indirectly connected to those who are quarantined. There appears to be a need to synthesise the available literature evidence on the psychological impact of quarantine experience, especially the multilevel risk factors that make individuals vulnerable to psychological impact and the protective factors to deal with the negative effects of quarantine. Objective: This systematic review attempted to identify the various psychological impacts associated with the experience of quarantine, the risk and protective factors and list out various psycho-social interventions that can minimise the risks and facilitate the protective factors associated with the experience of quarantine. Methods: A systematic search adhering to the PRISMA guidelines was performed in four databases PubMed, Scopus, PsycNet, Web of Science and 10518 articles related to COVID-19 and quarantine were obtained. After screening processes and quality assessment using standard checklist 74 articles that fulfilled the eligibility criteria were chosen for the final review. Findings: Individuals subjected to quarantine had anxiety, depression, post-traumatic stress symptoms, sleep problems, and somatic difficulties. Some of the key risk factors during quarantine are young age, female gender, low money, fear of infection, poor sleep quality, reduced physical activity, increased sedentary behaviours, and a lack of social support. Financial difficulties and stigma remained risk factors even after the quarantine period had ended. Key protective factors were coping skills, home based exercise, leisure, recreational activities, maintaining relationships using social media and availability of mental health services. The findings also highlight the necessity for tele mental health interventions to address the psychological effects of quarantine. Conclusion: Multilevel interventions are required to minimise the impact of risk factors and enhance protective factors.

5.
Allergy Rhinol (Providence) ; 12: 21526567211049744, 2021.
Article in English | MEDLINE | ID: covidwho-1467935

ABSTRACT

INTRODUCTION: Different subtypes of vaccines have been developed to help protect populations from COVID-19. Currently, three vaccines have been authorized by the United States Food and Drug Administration for emergency use to combat the COVID-19 pandemic. With COVID-19 vaccination rates increasing, it is important to know whether immunodeficient patients have the capacity to mount an immune response with the available vaccines. CASE REPORT: A 78-year-old female with Common Variable Immunodeficiency and anti-IgA antibodies who is naïve to IVIgG treatment responded positively to a COVID-19 mRNA vaccine. Successful seroconversion was proved by having positive COVID-19 spike protein IgG antibodies weeks after the vaccination. Her recent IgG, IgA, and IgM levels were all significantly reduced. Previously, she had no response to the polysaccharide pneumococcal vaccine, but did maintain titers afterTdap vaccination. DISCUSSION: Immunodeficient patients are a susceptible population during a pandemic. Unfortunately, there is a paucity of research on the infectivity, vaccination, and outcome of these patients during the COVID-19 outbreak. Our patient with CVID was able to respond to protein/toxoid vaccines, but did not respond to polysaccharide pneumococcal vaccine. After inoculation with an mRNA COVID-19 vaccine she was able to create COVID-19 spike protein IgG antibodies. CONCLUSION: We present a case of successful vaccination to COVID-19 by an mRNA vaccine in an IVIgG naïve CVID patient.

6.
Rev Med Virol ; 30(5): e2115, 2020 09.
Article in English | MEDLINE | ID: covidwho-628821

ABSTRACT

The current coronavirus pandemic has reached global proportions and requires unparalleled collective and individual efforts to slow its spread. One critically important issue is the proper sterilization of physical objects that have been contaminated by the virus. Here, we review the currently existing literature on thermal inactivation of coronavirus (SARS-CoV-2) and present preliminary guideless on temperatures and exposure durations required to sterilize. We also compare these temperatures/exposure durations with potential household appliances that may be thought capable of performing sterilization.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Sterilization/methods , Betacoronavirus/physiology , COVID-19 , Coronavirus Infections/virology , Hot Temperature , Humans , Pneumonia, Viral/virology , Practice Guidelines as Topic , Public Health , SARS-CoV-2 , Sterilization/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL